Breaking News, Promotions & Moves

Aprecia Names Owen Murray as Its CEO

Most recently served in VP role at Recordati Rare Diseases.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Aprecia Pharmaceuticals has named Owen Murray as its new CEO. Murray will lead the expansion of Aprecia’s offerings in proprietary 3D-printed (3DP) pharmaceutical technologies. “Owen has a unique background in both healthcare innovation and pharmaceutical commercialization,” said E. Thomas Arington, chairman, Aprecia. “His expertise will position Aprecia to further capitalize on exciting growth opportunities, by bringing value to partners and solutions to the unmet needs of patien...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters